The Role of Hematopoietic Cell Transplantation in Ataxia-Telangiectasia

The authors investigate the role of hematopoietic cell transplantation (HCT) in treating ataxia-telangiectasia (A-T), a condition characterized by immunodeficiency and cancer predisposition. They review existing literature on HCT outcomes, conditioning regimens, and associated toxicities, finding that reduced-intensity regimens are better tolerated and more effective than myeloablative approaches. The study concludes that while HCT may benefit select high-risk A-T patients, further research and collaboration are necessary to establish best practices.